#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Chorioretinitis B-cell lymphoma refractory Mycobacterium abscessus infection Non-small cell lung cancer recurrent Neuroblastoma Cold type haemolytic anaemia Hereditary angioedema with C1 esterase inhibitor deficiency Arteriovenous malformation B-cell lymphoma recurrent Richter's syndrome Congenital megacolon Haemophilia Oropharyngeal cancer recurrent Infantile spasms More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Treatment Bronchiolitis obliterans syndrome – Trials in Disease Soft tissue sarcoma – Life with Disease Cystic fibrosis – Trials in Disease Toxic epidermal necrolysis – Basic Information Glomerulonephritis membranous – Trials in Disease Alagille syndrome Loeys-Dietz syndrome Synovial sarcoma – Basic Information Prolymphocytic leukaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Delafloxacin Treosulfan Pervi-Fus Resiniferatoxin Avatrombopag Ketotifen Hydrogen Fumarate Ifezuntirgene Inilparvovec Midazolam Hydrochloride Leflunomide Duloxetine Idelalisib Insulin Glargine Gsk3858279 Alks 2680 Taminadenant Elinzanetant Ethanol, Anhydrous Transcon Il-2Β/Γ Mva-209-Fsp-B1 NADOFARAGENE FIRADENOVEC More therapies…

    Learn about Your Condition

    B-cell lymphoma Naevoid melanoma Splenic marginal zone lymphoma Gouty arthritis Tuberous sclerosis complex External cephalic version Naevus flammeus Mesothelioma malignant Obstructive airways disorder Prostate cancer recurrent Colour blindness Tissue anoxia Short-bowel syndrome Compulsive sexual behaviour Huntington's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Randomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome

    Not yet recruiting

    2 1
    Investigated Diseases:
    • VEXAS syndrome
    Italy

  • Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Crinecerfont
    Austria Bulgaria Czechia Germany Italy Portugal +3

  • Phase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    France Germany Italy Spain

  • Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rilvegostomig
    • Pembrolizumab
    Spain

  • Effect of liraglutide on immune response to pneumococcal polysaccharide vaccine in adults with diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 17F
    • Pneumococcal Polysaccharide Serotype 2
    • Pneumococcal Polysaccharide Serotype 20
    The Netherlands

  • Phase 2/3 Randomized Study of SKY-0515 for Safety and Efficacy in Adults with Huntington’s Disease

    Not yet recruiting

    4 1
    Germany Spain
Previous Page
1 … 673 674 675 676 677 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!